Company intelligence / Profile preview

RainMed Medical

Ownership: Private
Employees: ~270
Development stage: Commercial

Overview

RainMed’s core products—caFFR and caIMR systems—are commercialized and used for less-invasive physiological assessment of coronary artery ischemia severity and measurement of microcirculatory resistance. These products have been validated in clinical research published in leading cardiovascular journals. The company has also developed the FlashBot vascular interventional surgical robot to support precision interventions[1][2][3].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Strategic cooperation agreements with top domestic medical device distribution service platformscollaborations with top medical centers and experts globally

Beyond the preview

Go deeper on RainMed Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RainMed Medical.

Explore the full profile